Nurse Practitioner, Family · Elmhurst, NY
NPI
1275787624
Since 2008
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
79-01 Broadway, Elmhurst Hospital, Infectrion Control and Tuberculosis Services
Elmhurst, NY, 11373
Phone (718) 334-3078
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
455 services
Medicare patients, 2024
54
Average age 66
Drug cost, 2024
$4.9M
2,767 prescriptions
Company payments, 2025
$70.63
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald T Field I was code 99214 (office e&m - established), 74 times for 48 patients. In total Gerald T Field I billed 455 services in 11 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 74 | 48 | $88.57 | $6,554 |
By year: 2022 $6,685 for 124 services; 2023 $8,858 for 149 services; 2024 $15K for 455 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gerald T Field I prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 389 prescriptions and refills. In total Gerald T Field I wrote 2,767 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 389 | 409 | 59 | $1.5M |
| Tivicay Dolutegravir Sodium | 214 | 214 | 27 | $543K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 149 | 153 | 17 | $546K |
| Descovy Emtricitabine/Tenofov Alafenam | 143 | 163 | 20 | $344K |
| Atorvastatin Calcium Generic | 121 | 137 | 19 | $435 |
| Amlodipine Besylate Generic | 119 | 154 | 18 | $264 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 117 | 127 | 16 | $492K |
| Juluca Dolutegravir/Rilpivirine | 112 | 112 | 11 | $379K |
| Dovato Dolutegravir Sodium/Lamivudine | 70 | 70 | 12 | $199K |
| Ritonavir Generic | 62 | 72 | Under 11 | $11K |
| Metformin Hcl Generic | 51 | 55 | Under 11 | $208 |
| Hydrochlorothiazide Generic | 44 | 44 | Under 11 | $90.26 |
| Zolpidem Tartrate Generic | 44 | 44 | Under 11 | $147 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 44 | 44 | 11 | $1,457 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 38 | 38 | Under 11 | $338 |
Brand drugs: 1,524 claims; generic drugs: - claims; opioid claims: 84.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald T Field I $70.63 ($70.63 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $70.63.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 3 | $70.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.